Cleveland Clinic’s Post

Often I see clozapine used as a last resort instead of a first line of defense against schizophrenia. It ends up being administered after years of psychotic breaks and subsequent brain damage. We need more prescribers of clozapine and less red tape. Yes, there are side effects and monitoring concerns, but we need to weigh that against the risks of not using it. #psychosis #schizophrenia #clozapine #psychiatry #psychology #psychologist #psychotherapy #mentalhealthmatters #mentalhealthprofessionals #mentalhealthrecovery

In a new opinion paper, leading psychiatrists and researchers examine common assumptions about the term “psychedelic-assisted psychotherapy” and the role of psychotherapy when evaluating psilocybin treatment. The authors call for clarity on the definition of “psychedelic-assisted therapy” using psilocybin. https://yhoo.it/3pUblHP #oped #opinionpaper #research #therapy #psilocybin #pychedelics #mentalhealth

On 32. European Psychiatric Association Congress I presented research results about plasma concentrations of IL-8, IFN-γ and IL-1β in schizophrenia patients with subgroup analysis of first episode drug naïve patients Our research did not find disturbance of plasma levels of IFN-γ and IL-1β in schizophrenia patients, although the increase of IL-1β was the most replicated finding up to date. Interestingly and contrary to expected the finding of significantly decreased levels of IL-8 in schizophrenia patients requires further research since IL-8 plays a vital role in the inflammatory pathway and may be implicated in cognitive dysfunction. Further research on correlation of circulating levels of IL-8 and cognitive functioning in schizophrenia patients is needed.

"With a response rate of about 13%, the researchers said that a “majority moderately/strongly believed that hallucinogens show promise in treating psychiatric conditions (80.9%) and substance use disorders (SUDs) (60.8%).” “Large majorities also moderately/strongly supported research into hallucinogens’ therapeutic potential for psychiatric conditions (93.9%) and SUDs (88.6%), as well as federal funding of associated clinical trials (84.7% and 80.9%, respectively),” the researchers wrote. “Comparisons to 2016 showed significantly increased optimism regarding the therapeutic promise of hallucinogens and decreased concern about risks, with 50.4% of respondents reporting moderate/strong intentions to incorporate hallucinogen-assisted therapy into their practice." Psychedelic Insights provides the guidance of #private high dose legal psilocybin truffle experiences for personal transformation. Guided by experienced professionals. For more information, testimonials and our staff or to schedule a call to have all your questions answered, please see: https://lnkd.in/eJgb7Hk https://lnkd.in/eV7xaX-g

Why are randomized clinical trials involving psychiatric patients always relatively small? Every week, large trials are published with thousands of participants in influential medical journals, but rarely do these trials focus on psychiatric populations. We are discussing this topic in our recently published article in Lancet Regional Health. In this article, we argue the need to focus less on symptom scales and more on hard binary effect targets as the primary effect targets in psychiatric trials. We argue that if we are to talk about equality between physical and mental disorders, then this equality should also apply to research. Hope you will read along 🙂

Who is responsible for the rise in sales of psychiatric pills? Not psychiatrists!! Despite low psychiatrist visits, combination-drug sales soared 1,000% in 2023. Along with withdrawal, relapse, and more for users Lets Deep Dive into detailed story by Shivani Verma _ The Ken Dr Gorav Gupta from Emoneeds sharing his views !! #medication #mentalhealth #mentalhealthawareness #mentalhealthsupport #therapy

What should you know about palliative psychopharmacology? Examine the symptom-reducing or disease-modifying effects that psychiatric medications have, and more with AMA Journal of Ethics. https://lnkd.in/gEDA47F2

➖ Emyria Specialist Granted Authorised Prescriber Status ➖ Emyria (ASX:EMD) is pleased to announce the Company’s distinguished psychiatry specialist has been granted "Authorised Prescriber" status by the Therapeutic Goods Administration. This authorisation reflects Emyria's dedication to developing and delivering new mental health care options for the treatment of Post-Traumatic Stress Disorder (PTSD) under strict regulatory, ethical, and safety standards. It signifies a strategic step towards expanding Emyria's service offerings within the TGA guidelines. PTSD affects approximately 1 million Australians, and there is a growing need for more effective treatments. Emyria is currently studying MDMA-assisted therapy (MDMA-AT) for PTSD in an ethics-approved clinical trial (EMDMA-001). Experience with the trial has informed a unique delivery model for Emyria’s Authorised Prescriber program. Dr. Michael Winlo, CEO and MD, stated: "This authorisation demonstrates Emyria’s commitment to evaluating emerging treatments within the strict regulatory framework set by the TGA. “Emyria’s expertise and track record in innovative clinical service development and Real-World Data capture uniquely positions us to evaluate new therapeutic options in a safe and responsible way. Achieving Authorised Prescriber status showcases Emyria's capacity for impactful and responsible growth in the field of mental health treatments." Read today’s ASX release 👉 https://lnkd.in/eKD9EpbG $EMD #EMD #innovation #mentalhealth #biotech #healthcare #Emyria #PTSD #MDMAresearch

79% of psychiatrists recommend immediate treatment with an antidepressant to an outpatient with depression, but only 39% of psychiatrists would immediately take an antidepressant if they personally had depression, while 61% would prefer watchful waiting. Most psychiatrists said they would not take a depot shot for ‘schizophrenia’ themselves, but they do recommend that to their patients. This study also showed that when psychiatrists are asked ‘what would you do in my situation?’ they do not tell the truth, and instead they recommend the harsher treatments, whilst for themselves, they wouldn’t take them. What a BRILLIANT study. Save this one and use it when you need it. https://lnkd.in/erSYvGZi